97 related articles for article (PubMed ID: 14619811)
1. What's your stroke risk after atrial fibrillation? Novel risk-scoring method is precise but not perfect.
Carlson MD
Health News; 2003 Nov; 9(11):4-5. PubMed ID: 14619811
[No Abstract] [Full Text] [Related]
2. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
Mant JW
Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
[No Abstract] [Full Text] [Related]
3. Closing in on ending the warfarin era for stroke prevention in nonvalvular atrial fibrillation.
Turi ZG
Catheter Cardiovasc Interv; 2009 Aug; 74(2):223-4. PubMed ID: 19642149
[No Abstract] [Full Text] [Related]
4. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
Hylek EM
Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
[No Abstract] [Full Text] [Related]
5. Preventing stroke in people with atrial fibrillation: a cross-sectional study.
de Lusignan S; van Vlymen J; Hague N; Thana L; Dzregah B; Chan T
J Public Health (Oxf); 2005 Mar; 27(1):85-92. PubMed ID: 15590708
[TBL] [Abstract][Full Text] [Related]
6. Warfarin and stroke outcomes in hemodialysis patients with atrial fibrillation.
Genovesi S; Santoro A
J Am Soc Nephrol; 2009 Oct; 20(10):2090-2. PubMed ID: 19713302
[No Abstract] [Full Text] [Related]
7. Anticoagulation in the octogenarian with atrial fibrillation.
Kapoor M; McNicoll L
Med Health R I; 2009 Apr; 92(4):152-4. PubMed ID: 19452760
[TBL] [Abstract][Full Text] [Related]
8. Stroke prevention in atrial fibrillation--pharmacologic strategies.
Tiyyagura SR; Goldbarg SH; Mehta D
Indian Heart J; 2007; 59(4):311-5. PubMed ID: 19126935
[TBL] [Abstract][Full Text] [Related]
9. Clinical inquiries. Does combining aspirin and warfarin decrease the risk of stroke for patients with nonvalvular atrial fibrillation?
Robertson SL; Mayer JB; Guthmann R
J Fam Pract; 2004 Jul; 53(7):570-5. PubMed ID: 15251100
[No Abstract] [Full Text] [Related]
10. Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study).
Friberg L; Hammar N; Ringh M; Pettersson H; Rosenqvist M
Eur Heart J; 2006 Aug; 27(16):1954-64. PubMed ID: 16847008
[TBL] [Abstract][Full Text] [Related]
11. Oral anticoagulant therapy in patients with atrial fibrillation.
Pengo V
Semin Vasc Med; 2003 Aug; 3(3):333-8. PubMed ID: 15199467
[TBL] [Abstract][Full Text] [Related]
12. Anti-thrombotic therapy for atrial fibrillation and patients' preferences for treatment.
Lane D; Lip GY
Age Ageing; 2005 Jan; 34(1):1-3. PubMed ID: 15591476
[No Abstract] [Full Text] [Related]
13. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
Själander A; Wallentin L; Rosenqvist M; Svensson P
Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
[No Abstract] [Full Text] [Related]
14. Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment.
Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
Thromb Haemost; 2009 May; 101(5):938-42. PubMed ID: 19404548
[TBL] [Abstract][Full Text] [Related]
15. A cautionary note on data sources for evidence-based clinical decisions: warfarin and stroke prevention.
Thomson R; Eccles M; Wood R; Chinn DJ
Med Decis Making; 2007; 27(4):438-47. PubMed ID: 17641140
[TBL] [Abstract][Full Text] [Related]
16. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
Douketis JD; Arneklev K; Goldhaber SZ; Spandorfer J; Halperin F; Horrow J
Arch Intern Med; 2006 Apr; 166(8):853-9. PubMed ID: 16636210
[TBL] [Abstract][Full Text] [Related]
17. Intensity of anticoagulation in octogenarians with nonvalvular atrial fibrillation.
Jolobe OM
J Am Geriatr Soc; 2008 Oct; 56(10):1967-8. PubMed ID: 19054207
[No Abstract] [Full Text] [Related]
18. Does long-term warfarin affect the quality of life of older people?
Das AK; Willcoxson P; Corrado OJ
Age Ageing; 2005 May; 34(3):312-3. PubMed ID: 15863424
[No Abstract] [Full Text] [Related]
19. [New international guidelines on antithrombotic therapy in atrial fibrillation].
Tveit A
Tidsskr Nor Laegeforen; 2009 Jun; 129(13):1332-5. PubMed ID: 19561659
[TBL] [Abstract][Full Text] [Related]
20. [Anticoagulation in atrial fibrillation].
Binggeli C; Brunckhorst CB
Herz; 2008 Feb; 33(1):13-9. PubMed ID: 18273573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
